Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Wave Life Sciences (WVE) Receivables - Other (2018 - 2021)

Wave Life Sciences' Receivables - Other history spans 4 years, with the latest figure at $30.0 million for Q1 2021.

  • For Q1 2021, Receivables - Other changed 0.0% year-over-year to $30.0 million; the TTM value through Mar 2021 reached $30.0 million, changed 0.0%, while the annual FY2020 figure was $30.0 million, 50.0% up from the prior year.
  • Receivables - Other reached $30.0 million in Q1 2021 per WVE's latest filing, roughly flat from $30.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $60.0 million in Q3 2018 to a low of $10.0 million in Q2 2018.
  • Average Receivables - Other over 4 years is $34.2 million, with a median of $30.0 million recorded in 2020.
  • The largest YoY upside for Receivables - Other was 400.0% in 2019 against a maximum downside of 66.67% in 2019.
  • A 4-year view of Receivables - Other shows it stood at $60.0 million in 2018, then crashed by 66.67% to $20.0 million in 2019, then soared by 50.0% to $30.0 million in 2020, then changed by 0.0% to $30.0 million in 2021.
  • Per Business Quant, the three most recent readings for WVE's Receivables - Other are $30.0 million (Q1 2021), $30.0 million (Q4 2020), and $30.0 million (Q3 2020).